These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 19384159
1. Primary graft dysfunction in lung transplantation: the role of CD26/dipeptidylpeptidase IV and vasoactive intestinal peptide. Zhai W, Jungraithmayr W, De Meester I, Inci I, Augustyns K, Arni S, Hillinger S, Scharpé S, Weder W, Korom S. Transplantation; 2009 Apr 27; 87(8):1140-6. PubMed ID: 19384159 [Abstract] [Full Text] [Related]
2. The effect of organ-specific CD26/DPP IV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection. Jungraithmayr W, Oberreiter B, De Meester I, Wiedl T, Inci I, Bain M, Augustyns K, Hillinger S, Scharpé S, Weder W, Korom S. Transplantation; 2009 Aug 27; 88(4):478-85. PubMed ID: 19696630 [Abstract] [Full Text] [Related]
3. Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia. Zhai W, Cardell M, De Meester I, Augustyns K, Hillinger S, Inci I, Arni S, Jungraithmayr W, Scharpé S, Weder W, Korom S. J Heart Lung Transplant; 2007 Feb 27; 26(2):174-80. PubMed ID: 17258152 [Abstract] [Full Text] [Related]
4. Ischemia/reperfusion injury: The role of CD26/dipeptidyl-peptidase-IV-inhibition in lung transplantation. Zhai W, Cardell M, De Meester I, Augustyns K, Hillinger S, Inci I, Arni S, Jungraithmayr W, Scharpé S, Weder W, Korom S. Transplant Proc; 2006 Dec 27; 38(10):3369-71. PubMed ID: 17175274 [Abstract] [Full Text] [Related]
5. Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic mouse lung transplants: the pivotal role of vasoactive intestinal peptide. Jungraithmayr W, De Meester I, Matheeussen V, Inci I, Augustyns K, Scharpé S, Weder W, Korom S. Peptides; 2010 Apr 27; 31(4):585-91. PubMed ID: 20018218 [Abstract] [Full Text] [Related]
6. Vasoactive intestinal peptide ameliorates reperfusion injury in rat lung transplantation. Nagahiro I, Yano M, Boasquevisque CH, Fujino S, Cooper JD, Patterson GA. J Heart Lung Transplant; 1998 Jun 27; 17(6):617-21. PubMed ID: 9662098 [Abstract] [Full Text] [Related]
7. CD26/dipeptidylpeptidase IV-targeted therapy of acute lung rejection in rats. Jung FJ, Yang L, De Meester I, Augustyns K, Cardell M, Hillinger S, Vogt P, Lardinois D, Scharpé S, Weder W, Korom S. J Heart Lung Transplant; 2006 Sep 27; 25(9):1109-16. PubMed ID: 16962474 [Abstract] [Full Text] [Related]
8. Sildenafil extends survival and graft function in a large animal lung transplantation model. Korom S, Hillinger S, Cardell M, Zhai W, Tan Q, Dutly A, Leskosek B, Weder W. Eur J Cardiothorac Surg; 2006 Mar 27; 29(3):288-93. PubMed ID: 16442298 [Abstract] [Full Text] [Related]
9. N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation. Inci I, Zhai W, Arni S, Hillinger S, Vogt P, Weder W. Ann Thorac Surg; 2007 Jul 27; 84(1):240-6; discussion 246. PubMed ID: 17588422 [Abstract] [Full Text] [Related]
10. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. Jungraithmayr W, De Meester I, Matheeussen V, Baerts L, Arni S, Weder W. Eur J Cardiothorac Surg; 2012 May 27; 41(5):1166-73. PubMed ID: 22219460 [Abstract] [Full Text] [Related]
11. Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. Reece TB, Ellman PI, Maxey TS, Crosby IK, Warren PS, Chong TW, LeGallo RD, Linden J, Kern JA, Tribble CG, Kron IL. J Thorac Cardiovasc Surg; 2005 May 27; 129(5):1137-43. PubMed ID: 15867791 [Abstract] [Full Text] [Related]
13. Long-acting oral phosphodiesterase inhibition preconditions against reperfusion injury in an experimental lung transplantation model. Weiss ES, Champion HC, Williams JA, Baumgartner WA, Shah AS. J Thorac Cardiovasc Surg; 2009 May 27; 137(5):1249-57. PubMed ID: 19379999 [Abstract] [Full Text] [Related]
14. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin. Jang JH, Yamada Y, Janker F, De Meester I, Baerts L, Vliegen G, Inci I, Chatterjee S, Weder W, Jungraithmayr W. J Thorac Cardiovasc Surg; 2017 Mar 27; 153(3):713-724.e4. PubMed ID: 27939504 [Abstract] [Full Text] [Related]
16. Endobronchial gene transfer of soluble type I interleukin-1 receptor ameliorates lung graft ischemia-reperfusion injury. Tagawa T, Dharmarajan S, Hayama M, Ishiyama T, Suda T, Itano H, Patterson GA. Ann Thorac Surg; 2004 Dec 27; 78(6):1932-9; discussion 1939. PubMed ID: 15561003 [Abstract] [Full Text] [Related]
17. Experimental lung transplantation: impact of preservation solution and route of delivery. Wittwer T, Franke UF, Fehrenbach A, Ochs M, Sandhaus T, Schuette A, Richter S, Dreyer N, Knudsen L, Müller T, Schubert H, Richter J, Wahlers T. J Heart Lung Transplant; 2005 Aug 27; 24(8):1081-90. PubMed ID: 16102444 [Abstract] [Full Text] [Related]
18. Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. Li Z, Nickkholgh A, Yi X, Bruns H, Gross ML, Hoffmann K, Mohr E, Zorn M, Büchler MW, Schemmer P. J Pineal Res; 2009 May 27; 46(4):365-72. PubMed ID: 19552759 [Abstract] [Full Text] [Related]